Monoclonal antibodies
Identical antibodies made by cloned cells target one molecule, for drugs and tests.
Health and medicine · Biotechnology · No. 194
- Digital age
- Readiness 9 of 9
- Process
Fusing an antibody-making cell with a cancer cell in 1975 gave medicine an endless supply of identical, made-to-order antibodies.
Chart: Illustration: Monoclonal antibodies
Where it comes from
Chart: Map of where it comes from
Georges Köhler and César Milstein fused antibody-making cells with tumour cells in 1975. The fused cells lived on and kept making one antibody, and the pair shared the 1984 Nobel Prize.
Three things to know
- The first antibody medicine, approved in 1986, was a mouse protein, and patients' immune systems often attacked it.
- Chimeric antibodies followed in 1994, humanised ones in 1997 and fully human ones in 2002.
- In 2024 alone, 21 antibody medicines won a first approval somewhere in the world.
The journey
- 1 TargetPick one molecule, such as a protein on a cancer cell
- 2 Immune cellsFind cells that make an antibody against it
- 3 CloningMake those cells immortal so one line keeps making the same antibody
- 4 EngineeringMake the antibody more human so the body accepts it
- 5 Medicine or testProduce, purify and approve it for patients or laboratories